These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 34578352)

  • 41. Added value of IgA antibodies against Zika virus non-structural protein 1 in the diagnosis of acute Zika virus infections.
    Warnecke JM; Lattwein E; Saschenbrecker S; Stöcker W; Schlumberger W; Steinhagen K
    J Virol Methods; 2019 May; 267():8-15. PubMed ID: 30779938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue Virus Immune Mothers of Congenital Zika Virus Syndrome Infants.
    Reynolds CJ; Watber P; Santos CNO; Ribeiro DR; Alves JC; Fonseca ABL; Bispo AJB; Porto RLS; Bokea K; de Jesus AMR; de Almeida RP; Boyton RJ; Altmann DM
    Front Immunol; 2020; 11():185. PubMed ID: 32132999
    [No Abstract]   [Full Text] [Related]  

  • 43. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
    Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.
    Yamanaka A; Matsuda M; Okabayashi T; Pitaksajjakul P; Ramasoota P; Saito K; Fukasawa M; Hanada K; Matsuura T; Muramatsu M; Shioda T; Suzuki R
    mSphere; 2021 Aug; 6(4):e0033921. PubMed ID: 34259560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Engineered NS1 for Sensitive, Specific Zika Virus Diagnosis from Patient Serology.
    Yap TL; Hong SY; Soh JH; Ravichandraprabhu L; Lim VWX; Chan HM; Ong TZX; Chua YP; Koh SE; Wang H; Leo YS; Ying JY; Sun W
    Emerg Infect Dis; 2021 May; 27(5):1427-1437. PubMed ID: 33900180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of anti-premembrane antibody as a specific marker of four flavivirus serocomplexes and its application to serosurveillance in endemic regions.
    Chen GH; Dai YC; Hsieh SC; Tsai JJ; Sy AK; Jiz M; Pedroso C; Brites C; Netto EM; Kanki PJ; Saunders DRD; Vanlandingham DL; Higgs S; Huang YS; Wang WK
    Emerg Microbes Infect; 2024 Dec; 13(1):2301666. PubMed ID: 38163752
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a Rapid Diagnostic Test Kit to Detect IgG/IgM Antibody against Zika Virus Using Monoclonal Antibodies to the Envelope and Non-structural Protein 1 of the Virus.
    Kim YH; Lee J; Kim YE; Chong CK; Pinchemel Y; Reisdörfer F; Coelho JB; Dias RF; Bae PK; Gusmão ZPM; Ahn HJ; Nam HW
    Korean J Parasitol; 2018 Feb; 56(1):61-70. PubMed ID: 29529852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis of Zika virus infection on a nanotechnology platform.
    Zhang B; Pinsky BA; Ananta JS; Zhao S; Arulkumar S; Wan H; Sahoo MK; Abeynayake J; Waggoner JJ; Hopes C; Tang M; Dai H
    Nat Med; 2017 May; 23(5):548-550. PubMed ID: 28263312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of cross-reactivity between flaviviruses with sera of patients with Japanese encephalitis showed the importance of neutralization tests for the diagnosis of Japanese encephalitis.
    Maeki T; Tajima S; Ikeda M; Kato F; Taniguchi S; Nakayama E; Takasaki T; Lim CK; Saijo M
    J Infect Chemother; 2019 Oct; 25(10):786-790. PubMed ID: 31105002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The inability of a dengue NS1 ELISA to detect Zika infections.
    Lima MDRQ; Chouin-Carneiro T; Azeredo E; Barbosa LS; Souza TMA; Silva JBCD; Nunes PCG; Dal Fabbro M; Facco IHR; Venâncio-da-Cunha R; Dos Santos FB
    Sci Rep; 2019 Dec; 9(1):18596. PubMed ID: 31819129
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.
    Lim MQ; Kumaran EAP; Tan HC; Lye DC; Leo YS; Ooi EE; MacAry PA; Bertoletti A; Rivino L
    Front Immunol; 2018; 9():2225. PubMed ID: 30327651
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human antibody response to Zika targets type-specific quaternary structure epitopes.
    Collins MH; Tu HA; Gimblet-Ochieng C; Liou GA; Jadi RS; Metz SW; Thomas A; McElvany BD; Davidson E; Doranz BJ; Reyes Y; Bowman NM; Becker-Dreps S; Bucardo F; Lazear HM; Diehl SA; de Silva AM
    JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serological tests reveal significant cross-reactive human antibody responses to Zika and Dengue viruses in the Mexican population.
    Zaidi MB; Cedillo-Barron L; González Y Almeida ME; Garcia-Cordero J; Campos FD; Namorado-Tonix K; Perez F
    Acta Trop; 2020 Jan; 201():105201. PubMed ID: 31562846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specificity of Dengue NS1 Antigen in Differential Diagnosis of Dengue and Zika Virus Infection.
    Matheus S; Boukhari R; Labeau B; Ernault V; Bremand L; Kazanji M; Rousset D
    Emerg Infect Dis; 2016 Sep; 22(9):1691-3. PubMed ID: 27347853
    [No Abstract]   [Full Text] [Related]  

  • 56. Capacity of a Multiplex IgM Antibody Capture ELISA to Differentiate Zika and Dengue Virus Infections in Areas of Concurrent Endemic Transmission.
    Medina FA; Vila F; Premkumar L; Lorenzi O; Paz-Bailey G; Alvarado LI; Rivera-Amill V; de Silva A; Waterman S; Muñoz-Jordán J
    Am J Trop Med Hyg; 2021 Dec; 106(2):585-592. PubMed ID: 34929668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of the immunoglobulin G avidity assay to differentiate between recent Zika and past dengue virus infections.
    Furuya AKM; Hunt D; George KS; Dupuis AP; Kramer LD; Shi PY; Wong S
    Clin Sci (Lond); 2019 Apr; 133(7):859-867. PubMed ID: 30902827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of Zika Virus Serological Testing Strategies in New York State.
    Lee WT; Wong SJ; Kulas KE; Dupuis AP; Payne AF; Kramer LD; Dean AB; St George K; White JL; Sommer JN; Ledizet M; Limberger RJ
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Competitive ELISA for a serologic test to detect dengue serotype-specific anti-NS1 IgGs using high-affinity UB-DNA aptamers.
    Matsunaga KI; Kimoto M; Lim VW; Thein TL; Vasoo S; Leo YS; Sun W; Hirao I
    Sci Rep; 2021 Sep; 11(1):18000. PubMed ID: 34504185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An antibody panel for highly specific detection and differentiation of Zika virus.
    Kabir MA; Soto-Acosta R; Sharma S; Bradrick SS; Garcia-Blanco MA; Caputi M; Asghar W
    Sci Rep; 2020 Jul; 10(1):11906. PubMed ID: 32681135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.